laminin and fibronectin increase the steady state level of the 67 kd high affinity...
TRANSCRIPT
Vol. 168, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
May 16, 1990 Pages 1110-1117
Laminin and fibronectin increase the steady state
level of the 67 kD high affinity metaatask-associated
laminin receptor UIRNA in human cancer cells
Vincent Castronovo*and Mark E. Sobel
Tumor Invasion and Metastasis Section, Laboratory of Pathology,
National Cancer Institute, Bethesda , Maryland 20892
Received March 9, 1990
Among the various known laminin binding proteins, the 67 kD
high affinity laminin receptor (LR) is intimately involved
during tumor invasion and metastasis. In this study, we report
that laminin and fibronectin, two attachment glycoproteins,
significantly increased the total cellular level of 67 kD LR mRNA
in two human cancer cell lines, T47D breast carcinoma cells and
A2058 melanoma cells. Neither GRGDS nor YIGSR synthetic peptides
induced such a stimulatory effect. Since the steady state level
of LR mRNA has been shown to control the number of receptors
expressed at the cell surface, these results suggest that
contact of the cancer cells with laminin and fibronectin in the
host matrix may be an important regulatory mechanism by which
cancer cells maintain a high number of LR at their cell surface
as they progress through the several steps of tumoral invasion
and metastasis. 01990 Academic Press, Inc.
Tumor invasion and metastasis are the result of complex
pathological interactions between malignant cells and host stroma
(l-3). During their progression, the invading tumor cells have to penetrate and traverse a number of tissue compartments separated
from each other by two types of extracellular matrix:
interstitial matrix and basement membranes (1,2). The latter are
specialized thin extracellular sheets which constitute barriers
that cancer cells must cross (1,4). A major event during tumoral
*To whom correspondence and reprint requests should he addressed at Laboratory of Pathology, National Cancer Institute, NIH, Building 10, Room 2A33, Bethesda, MD 20892.
0006-291x/90 $1.50 Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in any form reserved. 1110
Vol. 168, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
invasion and metastasis is the attachment of cancer cells to
both types of extracellular matrix, mediated by cell surface
receptors to attachment factors such as fibronectin and laminin
(l-3,5) .
Laminin is the major component of basement membrane (6). Interactions between laminin and cancer celis are important at
several steps of the metastatic cascade (1,2,7) and are mediated
through several laminin binding proteins (8-12). Among these, a
67 kD high affinity laminin receptor appears to be intimately
involved during tumor invasion and metastases (8,13,14). A strong
direct correlation has been observed between the number of 67 kD
laminin receptors expressed at the cell surface and the
metastatic capabilities of malignant cells, particularly in
breast and colon cancer (1,15,16). Estrogen and progesterone,
known to modulate the invasive and metastatic potential of
steroid receptor positive breast cancer cells, significantly increased the expression of laminin receptor both at the protein
and the mRNA level in human breast carcinoma T47D cells (17).
cDNA clones encoding the 67 kD laminin receptor have been
identified both in human and mouse (16, 18-20). RNA blot
analysis showed that the steady state level of 67 kD laminin
receptor mRNA correlated directly with the number of cell surface
laminin receptors in a variety of human cancer cells (18). The
synthesis of the receptor in most cells thus appears to be
controlled by the amount of mRNA available for translation.
During invasion, cancer cells actively influence the
surrounding extracellular matrix (1). In return, the host extracellular matrix components exert biochemical and
mechanical influences on the cancer cell via plasma membrane receptors (21). Fibronectin and laminin are known to stimulate
attachment, spreading, migration and proliferation of normal and
cancer cells (1,5). In addition, laminin has been shown to
stimulate the production of type IV collagenase by malignant
melanoma cells (21). Thus, attachment of the tumor cell to the
basement membrane via laminin receptor(s) may induce a cascade
of events, one of which is production of proteolytic enzymes to
degrade other components of the basement membrane such as type
IV collagen.
The three-step hypothesis suggested by Liotta et al. (1) proposed that continued invasion of the matrix may take place by
cyclic repetition of tumor cell attachment, local degradation of
the matrix and cell locomotion into the altered matrix. This
1111
Vol. 168, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
theory implies a high turnover in the synthesis of several gene
products involved in each of these steps. Expression of the 67 Kd
laminin receptor is probably involved in the attachment step.
Since the mRNA level of this receptor controls the number of
receptors expressed at the cell surface (18), we examined in this
study the possible modulation of laminin receptor mRNA levels in cancer cells by laminin or fibronectin.
MATERIAL AND METHODS
Cell Lines and Culture Conditions The human breast carcinoma T47D cell line was obtained
from the American Tissue Type Collection. Human melanoma A2058 cells were previously described (23). The cells were routinely grown in Dulbecco's modified Eagles medium (DMEM) supplemented with 10 % heat inactivated fetal bovine serum, penicillin (100 pg/ml) and streptomycin (100 ug/ml) obtained from Gibco, in an atmosphere of 5% CO2/95% air under saturating concentrations of humidity at 37OC.
Attachment glycoproteins and synthetic peptides Laminin was purified from the mouse Engelbreth-Holm-Swarm
sarcoma as described (6). Human fibronectin was purchased from Collaborative Research, Inc. The purity of both laminin and fibronectin was verified by gel electrophoresis. Synthetic peptides (YIGSR, YIGSE, GRDGS and GRGES) were synthesized on a Biosearch 9600 peptide synthesizer.
Attachment factor effect assays Plastic culture dishes (diameter 13.5 cm, Falcon 3025) were
coated with laminin or fibronectin by incubation overnight at 370 with 15 ml of a solution containing 10 fig/ml laminin or fibronectin in phosphate buffered saline (PBS), 2% bovine serum albumin (BSA), pH 7.4. After the coating, the dishes were washed twice with PBS containing 2% BSA. A2058 or T47D cells were harvested at a preconfluent stage of growth by treatment with 0.1% trypsin/SmM ethylene-diaminetetraacetic acid. The cells were washed twice in DMEM without serum and added in the same medium to the plastic culture dishes coated with laminin or fibronectin. Uncoated plastic dishes were used as control. To investigate the possible effect of the synthetic peptides YIGSR or GRGDS on the level of laminin receptor mRNA , plastic culture dishes were coated with these peptides as well as with their corresponding controls (YIGSE and GRGES, respectively), following the same protocol described for laminin and fibronectin. In some experiments, the peptides were added at a concentration of 50 pg/ml to the culture medium of A2058 or T47D cells which were seeded on control plastic dishes.
RNA blot analysis Total cellular RNA was isolated from cells grown in
the absence of serum on laminin , fibronectin or plastic for 24 hours using the guanidium thiocyanate method as described (24). After electrophoresis on 1.0% gels containing methyl- mercuric hydroxide as the denaturing agent, the fractionated RNA was transferred to activated diazobenzyloxymethyl cellulose paper (Schleicher & Schuell) .as described (25) and hybridized to
1112
Vol. 168, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
nick translated 32P-labeled laminin receptor cDNA insert (18) for 16-24 h at 420 C. After hybridization, blots were stringently washed as described (25), and exposed to X-ray film using Cronex Hi plus intensifying screens (DuPont). Blots were stripped free of probe by incubating in 99% formamide and then water, both at 70° C for 5 min, followed by exposure to X-ray film to ensure complete removal of probe. Blots were subsequently hybridized with beta-actin cDNA (26) as a control to rule out differences in the amount of RNA loaded on the gel. Hybridization signals were quantified by densitometric scanning of multiple autoradiograms of various timed exposures. In some experiments, RNA slot blots (Schleicher & Schuell) containing 1, 5 and 10 pg total cellular RNA were hybridized to the cDNA probes.
RESULTS
Levels of laminin receptor mRNA in A2058 and T47D cells which
had been cultured for 24 hours on plastic, laminin or fibronectin
were determined by Northern and slot blot hybridizations. As
shown in figure 1, the laminin receptor cDNA probe hybridized to
a unique size transcript of approximately 1,400 bases. In both
melanoma and breast cancer cell lines, attachment to laminin and
fibronectin increased the level of laminin receptor mRNA. The
effect of fibronectin was more pronounced than that of laminin.
P L F P L F fj 300, ,
1,400 E - 4 B E IOO- 0 z K E 2
0 1 A2058 T47D A2058 T47D
Figure 1. Nothern blot hybridization. Cells were cultured for 24 hours on plastic (P), laminin (L) or fibronectin (F). Total cellular RNA extracted from A2058 or T47D cells was hybridized with a human laminin receptor cDNA probe as described in Methods. The length of the hybridized mRNA (1400 bases) was dete.rmined by comparison with the known size of rRNA and with the sizes of lambda DNA digested with Hind III.
Figure 2. Modulation of laminin receptor mRNA levels in A2058 and T4lD cells by laminin and fibronectin. Each column represents the laminin receptor mRNA level (+ SD) quantified bv densitometrv and expressed relative to the amount of a&in mRNA, as described-in Methods. The cells were grown on plastic ( n ), laminin ( q ) or fibronectin ( q ). Each experiment was repeated at least twice.
1113
Vol. 168, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Indeed, the relative steady state level of the laminin receptor
mRNA was 1.96 times higher in A2058 cells grown on laminin than
on plastic (p< 0.001) and 2.8 times higher in A2058 cells grown
on fibronectin than on plastic (pl 0.001) (fig. 2). A comparable
stimulatory effect was observed in T47D cells. In the latter, the
steady state level of laminin receptor mRNA was 1.4 fold and
1.94 fold higher in cells grown on laminin or fibreonectin,
respectively, than in cells grown on plastic (ps 0.001) (fig. 2).
The more pronounced effect of fibronectin over laminin was
significant in both A2058 and T47D cells (p< 0.008).
It has been reported that YIGSR and GRGDS are amino acid
sequences which can mimic some of the biological activities of
laminin or fibronectin respectively (27-29). We investigated the
possibility that the stimulatory effect of laminin and
fibronectin on the steady state level of laminin receptor mRNA
could be produced by exposure of cancer cells to these
synthetic peptides. Thus, the melanoma and breast cancer cells
were grown for 24 hours on YIGSR- or GRGDS- coated plastic
dishes. As a control, cells were grown on plastic dishes coated
with the corresponding inactive peptide YIGER or GRGES,
respectively. The analysis of the RNA extracted from these
140
I 120
SP s2.j 100
I
EC 4”2
60
3% c,zw 60 zs 45 $2 40
20
0 3 0 lu-a A2056 T47D
140
0 4 O A2056 T47D
Figure 3. Modulation of laminin receptor mRNA levels in A2058 and T47D cells by YIGSR ( H) and its control peptide YIGSE (H). Each column represents the laminin receptor mRNA level (+ SD) quantified by densitometry as described in figure 2. Figure 4. Modulation of laminin receptor mRNA level in A2058 and T47D cells by GRGDS ( n ) and its control peptide GRGES (H,. Each column represents the laminin receptor mRNA level (5 SD) quantified by densitometry as described in figure 2.
1114
Vol. 168, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
cells after 24 hours showed that neither YIGSR (fig. 3) nor
GRGDS (fig. 4) induced a signficant increase in the steady
state level of laminin receptor mRNA.
DISCUSSION
Tumor invasion and metastasis are the result of complex
pathological interactions between malignant tumor cells and the
host stroma. These interactions affect both the host tissues and
the cancer cells. Malignant cells degrade the matrix in
actively invaded areas , induce production of matrix components
by host cells in response to the local presence of the tumor,
or may themselves synthesize and deposit matrix components such
as collagen (1,2). Conversely, the host extracellular matrix
regulates certain activities of cancer cells such as proteolytic
enzyme secretion or motility (1,2).
Attachment of cancer cells to extracellular matrix components,
especially to laminin and fibronectin, is an important event
occurring many times during tumoral invasion and metastasis
(1,3,5). This attachment is mediated through a variety of cell
surface receptors involving a variety of adhesion mechanisms.
Interaction between cancer cells and laminin has been the
subject of intensive studies over the past decade, since it is
considered to be a key step of the metastatic cascade (1). Among
several recently identified laminin binding cell surface
proteins (8-12), the 67 kD laminin receptor seems to be actively
used by cancer cells during the progression of tumor invasion and
metastasis. Indeed, increased cell surface expression of this
receptor has been correlated with the invasive and metastatic
capabilities of cancer cells (15,16). In highly invasive cancer
cells, the number of laminin receptors appears to be dramatically
increased and not saturated with laminin. In this study, we
showed that laminin significantly increased the level of mRNA in
two human cancer cell lines, A2058 and T47D. YIGSR, which has
been reported to inhibit cell attachment to laminin (27), was
unable to substitute for laminin in increasing the level of
laminin receptor mRNA. This suggests that the YIGSR sequence is
not sufficient to induce the laminin stimulatory effect.
Possibly, YIGSR is not the sequence of laminin responsible for
the interaction between the 67 kD laminin receptor and
laminin; it may bind bind to another cell surface laminin binding
protein to mediate its effect on cell attachment.
1115
Vol. 168, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Unexpectedly, fibronectin dramatically increased the level of
67 kD laminin receptor mRNA in both human melanoma and breast
cancer cell lines. The ability of cells to bind fibronectin and
related adhesion proteins appears to depend on a short,
hydrophilic amino acid sequence, RGDS, located in the cell
binding domain of the fibronectin molecule (28,29).
It has recently been reported that laminin also contains,
within its A chain, the sequence RGDS (30). We therefore tested
the hypothesis that the increase of laminin receptor mRNA levels
by fibronectin and by laminin was due to interaction of the cells
with this specific sequence. We showed that the peptide RGDS,
whether coated on plastic culture dishes or added in solution to
the culture medium, did not affect the level of laminin receptor
mRNA in A2058 and T47D cell lines. These results indicate that
the sequence RGDS is either not sufficient or is not involved at
all in the stimulatory effect observed.
During tumor progression, cancer cells synthesize and deposit
laminin. We showed previously an accumulation of laminin at the
invasive edge in both in vitro and in viva models for tumor
invasion (31). Fibronectin is a widely distributed extracellular
matrix protein (32). The induction of laminin receptor mRNA
following the interaction of cancer cells with laminin and/or
fibronectin may therefore be an important regulatory mechanism
which provides cancer cells with a continuous supply of laminin
receptors necessary for the continuation of tumor invasion and
metastasis.
REFERENCES
1.
2.
3.
4. 5.
6.
7.
8.
Liotta, L.A., Rao, C.N., and Barsky, S.H. (1983) Lab. Invest., 49, 639-649. Pauli, B.U., Scwartz, D.E., Thonar, E.J.-M. a Kuettner, K.E. (1983) Cancer Metast. Rev., 2, 129-151. Poste, G., and Fidler, I. (1980) Nature (Lond.), 283, 139-146. Vracko, R. (1974) Am. J. Pathol., 77, 313-346. Vlodavsky, I. and Gospodarowicz, D. (1981) Nature (Lond.), 289, 304-306. Timpl, R., Rhode, H., Robey, P.G., Rennard, S.I., Foidart, J.M., and Martin, G.R. (1979) J. Biol. Chem., 254, 9933-9941. Kleinman, H.K., Cannon, F.B., Laurie, G.W., Hassell, J.R., Aumailley, M., Terranova, V.P., Martin, G.R., and Dubois-Dalcq, M. J. (1985) Cell Biochem., 27, 317-325. Terranova, V.P., Rao, C.N., Kabelic, T., Margulies, I.M.K., and Liotta, L.A. (1983) Proc. Natl. Acad. Sci. USA, 80, 444-451.
1116
Vol. 166, No. 3, 1990 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21. 22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
Kleinman, H.K., Ogle, R.C., Cannon, F.B., Little, C.D., Sweeney, T.M., and Luckenbill-Edds, L. (1988) Proc. Natl. Acad. Sci. USA, 85, 1282-1286. Horwitz, A., Duggan, K., Greggs, R., Decker, C., and Buck, C.(1985) J. Cell Biol., 101, 2134-2144. Gehlsen, K.R., Dillner, L., Engvall, E., Ruoslahti, E (1988) Science, 241, 1228-1229. Kramer, R.H., McDonald, K.A. and Vu, M.P. (1989) J. Biol. Chem., 264, 15642-15649. Rao, C.N., Barsky, S-H., Terranova, V.P., and Liotta, L-A-(1983) Biochem. Biophys. Res. Commun., 111, 804-808. Malinoff, H., and Wicha, M.S. (1983) J. Cell Biol., 96,1475-1480. Horan Hand, P., Thor, A., Schlom, J., Rao, C.N., Liotta, L.A (1985) Cancer Res. 45, 2713-2719. Yow, H., Wong, J.M., Chen, H.S., Lee, C., Steele, G.D., JR., and Chen, L.B. (1988) Proc. Natl. Acad. Sci. USA, 85, 0 6394-6398. Castronovo, V., Taraboletti, G., Liotta, L.A. and Sobel, M.E. (1989) J. Natl. Cant. Inst., 81, 781-786. Wewer,U.M., Liotta, L-A., Jaye, M., Ricca, G.A., Drohan, W.N., Claysmith, A.P., Rao, C.N., Wirth, P., Coligan, J.E., Albrechtsen, R., Mudryj, M., Sobel, M.E. (1986) Proc. Natl. Acad. Sci. USA, 83, 7137-7141. Rao, C.N., Castronovo, V., Schmitt, M.C., Wewer, U.M., Claysmith, A.P., Liotta, L.A. and Sobel, M.E. (1989) Biochemistry, 28, 7476-7486. Makrides, S., Chitpatima, S.T., Bandyopadhyay, R., Brawerman, G. (1988) Nucleic Acids Res., 16, 2349. Yamada, K.M. Annu. Rev. Biochem. (1988), 52, 761-773. Turpeenniemi-Hujanen, T., Thorgeirsson, U.P., Rao, C.N. and Liotta, L.A. (1986) J. Biol. Chem., 261, 1883-1889. Wewer, U. M., Taraboletti, G., Sobel, M. E., Albrechtsen, R., Liotta, L.A. (1987) Cancer Res., 47, 5691-5698. Glisin, V., Crkvenjakov, R., and Byus, C.(1974) Biochemistry, 13, 2633-2637. Sobel, M.E., Yamamoto, T., de Crombrugghe, B., and Pastan, I. (1981) Biochemistry, 20,26788-2684. Cleveland, D.W., Lopata, M.A., MacDonald, R.J., Cowan, W.J., Rutta, W.J. and Kirschner, M.W. (1980) Cell, 20, 95-105. Graf, J., Ogle, R.C., Robey, F.A., Sasaki, M., Martin, G.R., Yamada, Y. and Kleinman, H.K. (1987) Biochemistry, 26, 6896-6900. Humphries, M.J., Olden, J.,Yamada, K.M.(1986) Science, 233,467-470. Rouslahti, E. and Pierschbacher, M.D. (1987) Science 238, 4910-4916. Sasaki, M., Kleinman, H.K., Huber, H., Deutzmann, R. and Yamada, Y. (1988) J. Biol. Chem., 263, 16536-16544. Castronovo, V., Bracke, M., Mareel, M., Foidart, J.M. (1985) Biology and Chemistry of Basement Membranes, pp 447-448, Elsevier, Amsterdan. Hynes, R.O.,Yamada, K.M. (1982) J. Cell Biology 95, 369-377.
1117